Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
19 Jan 2025
Genetic Mechanisms Driving Age-Related Clonal Haematopoiesis
Recent research has uncovered key insights into the genetic mechanisms driving age-related clonal haematopoiesis…
15 Jan 2025
Hema Now: Episode 8: What’s Next in Lymphoma Diagnosis and Treatment?
Marc Hoffman, Associate Professor in Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center discusses the future of lymphoma care.
14 Jan 2025
New FlowScore Metric Improves Red Blood Cell Quality Assessment
A new method for evaluating the functional quality of red blood cells could transform blood banking and clinical practices by providing a more accurate measure of how well RBCs deliver oxygen to tissues.
12 Jan 2025
Poor Outcomes for Leukaemia Patients After Myelodysplastic Syndrome Treatment
A study reveals poor survival outcomes for patients with acute myeloid leukaemia who previously received treatment for myelodysplastic syndrome.
10 Jan 2025
mRNA-Based T-Cell Therapy Offers Safer, More Affordable Cancer Treatment
A new study has introduced an innovative approach to CAR-T therapy that could address some of the current challenges in cancer treatment…
8 Jan 2025
Limited Value of Routine Follow-Up in Lymphoma Remission
Study reveals limited effectiveness of routine follow-up in detecting relapses in diffuse large B-cell lymphoma patients in remission.
6 Jan 2025
CAR-T Cell Therapy Shows Promise for Transformed Indolent Non-Hodgkin Lymphoma
A recent retrospective study has shed new light on the effectiveness of chimeric antigen receptor T cell therapy for patients with transformed indolent non-Hodgkin lymphoma….
2 Jan 2025
New Metric Offers Insight into Red Blood Cell Function and Quality
A recent study has introduced FlowScore, a new metric for evaluating the quality of red blood cells that goes beyond traditional haemoglobin assays…
Loading posts...
« Previous
1
…
27
28
29
30
31
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View